Crystal Rock Capital Management bought a new stake in Colgate-Palmolive (NYSE:CL) during the third quarter, HoldingsChannel reports. The institutional investor bought 27,500 shares of the company’s stock, valued at approximately $2,003,000. Colgate-Palmolive makes up about 1.3% of Crystal Rock Capital Management’s investment portfolio, making the stock its 27th biggest position.
A number of other hedge funds and other institutional investors also recently bought and sold shares of CL. Blue Chip Partners Inc. lifted its position in shares of Colgate-Palmolive by 0.4% during the second quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock worth $134,000 after purchasing an additional 8 shares in the last quarter. AlphaMark Advisors LLC lifted its position in shares of Colgate-Palmolive by 1.5% during the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares in the last quarter. Capital Investment Advisors LLC lifted its position in shares of Colgate-Palmolive by 0.3% during the second quarter. Capital Investment Advisors LLC now owns 8,318 shares of the company’s stock worth $617,000 after purchasing an additional 27 shares in the last quarter. Weatherstone Capital Management lifted its position in shares of Colgate-Palmolive by 0.7% during the second quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock worth $302,000 after purchasing an additional 28 shares in the last quarter. Finally, Dorsey & Whitney Trust CO LLC lifted its position in shares of Colgate-Palmolive by 0.6% during the second quarter. Dorsey & Whitney Trust CO LLC now owns 5,642 shares of the company’s stock worth $419,000 after purchasing an additional 34 shares in the last quarter. 72.83% of the stock is currently owned by institutional investors.
CL has been the topic of several research reports. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a research report on Monday, October 23rd. Deutsche Bank initiated coverage on shares of Colgate-Palmolive in a research report on Wednesday, December 13th. They set a “hold” rating and a $75.00 price target on the stock. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $75.00 to $84.00 in a research report on Monday, September 25th. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Finally, Stifel Nicolaus set a $73.00 price target on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Sunday, October 29th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $76.51.
Shares of Colgate-Palmolive (CL) opened at $74.55 on Friday. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. Colgate-Palmolive has a one year low of $63.43 and a one year high of $77.27. The firm has a market cap of $65,460.00, a P/E ratio of 28.78, a P/E/G ratio of 3.21 and a beta of 0.81.
Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same period in the prior year, the firm earned $0.73 earnings per share. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. analysts predict that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.15%. Colgate-Palmolive’s payout ratio is 61.78%.
WARNING: “Crystal Rock Capital Management Buys New Stake in Colgate-Palmolive (CL)” was published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.themarketsdaily.com/2018/01/12/crystal-rock-capital-management-buys-new-stake-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.